These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 27998471)
21. Economic burden of lung cancer attributable to smoking in China in 2015. Shi JF; Liu CC; Ren JS; Parascandola M; Zheng R; Tang W; Huang HY; Li F; Wang L; Su K; Li N; Zhang K; Chen WQ; Wu N; Zou XN; Liu GX; Dai M Tob Control; 2020 Mar; 29(2):191-199. PubMed ID: 31073096 [TBL] [Abstract][Full Text] [Related]
22. How great is current curative expenditure and catastrophic health expenditure among patients with cancer in China? A research based on "System of Health Account 2011". Zheng A; Duan W; Zhang L; Bao X; Mao X; Luo Z; Jin F Cancer Med; 2018 Aug; 7(8):4036-4043. PubMed ID: 29923330 [TBL] [Abstract][Full Text] [Related]
23. Analysis of treatment cost for neuroblastoma to the family: a single-center cross-sectional study in China. Jiang C; Cai S; Duan C; Xu N; Zhou Y; Peng X; Ma X J Med Econ; 2020 Sep; 23(9):961-966. PubMed ID: 32568600 [TBL] [Abstract][Full Text] [Related]
24. Main drivers of health expenditure growth in China: a decomposition analysis. Zhai T; Goss J; Li J BMC Health Serv Res; 2017 Mar; 17(1):185. PubMed ID: 28274228 [TBL] [Abstract][Full Text] [Related]
25. Medical expenditure for lung cancer in China: a multicenter, hospital-based retrospective survey. Zhang X; Shi JF; Liu GX; Ren JS; Guo LW; Huang WD; Shi LM; Ma Y; Huang HY; Bai YN; Liao XZ; Mao AY; Sun XJ; Zhu XY; Zhou Q; Gong JY; Zhou JY; Liu YQ; Mai L; Song BB; Zhu L; Xing XJ; Du LB; Qi X; Sun XH; Wu SL; Ren Y; Cao R; Lan L; Lou PA; Zhang K; He J; Dai M Cost Eff Resour Alloc; 2021 Aug; 19(1):53. PubMed ID: 34404418 [TBL] [Abstract][Full Text] [Related]
26. Economic cost analysis of malaria case management at the household level during the malaria elimination phase in The People's Republic of China. Xia S; Ma JX; Wang DQ; Li SZ; Rollinson D; Zhou SS; Zhou XN Infect Dis Poverty; 2016 Jun; 5(1):50. PubMed ID: 27255648 [TBL] [Abstract][Full Text] [Related]
27. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective. Sagar B; Lin YS; Castel LD J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874 [TBL] [Abstract][Full Text] [Related]
28. Medical resource utilization and the associated costs of asthma in China: a 1-year retrospective study. Yang X; Zhang T; Yang X; Jiang J; He Y; Wang P BMC Pulm Med; 2023 Nov; 23(1):463. PubMed ID: 37993799 [TBL] [Abstract][Full Text] [Related]
29. Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China. Mao W; Tang S; Zhu Y; Xie Z; Chen W Int J Equity Health; 2017 Oct; 16(1):180. PubMed ID: 29017542 [TBL] [Abstract][Full Text] [Related]
30. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017. Hristova L; Hakama M Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316 [TBL] [Abstract][Full Text] [Related]
31. Economic Burden for Lung Cancer Survivors in Urban China. Zhang X; Liu S; Liu Y; Du J; Fu W; Zhao X; Huang W; Zhao X; Liu G; Mao Z; Hu TW Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28294998 [TBL] [Abstract][Full Text] [Related]
32. The population-level economic burden of liver cancer in China, 2019-2030: prevalence-based estimations from a societal perspective. Cao MD; Liu CC; Wang H; Lei L; Cao M; Wang Y; Li H; Yan XX; Li YJ; Wang X; Peng J; Qu C; Feletto E; Shi JF; Chen W Cost Eff Resour Alloc; 2022 Jul; 20(1):36. PubMed ID: 35870941 [TBL] [Abstract][Full Text] [Related]
33. Impact of China's National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin. Zhao B; Wu J Int J Health Policy Manag; 2023; 12():7724. PubMed ID: 38618801 [TBL] [Abstract][Full Text] [Related]
34. Economic burden of cancer across the European Union: a population-based cost analysis. Luengo-Fernandez R; Leal J; Gray A; Sullivan R Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614 [TBL] [Abstract][Full Text] [Related]
35. [Disease burden of gastric cancer in Jinchang cohort]. Pei H; Pu H; Dai M; Bai Y; Chang S; Wang Z; Cheng N; Li H; Li J; Hu X; Ren X Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Mar; 37(3):316-20. PubMed ID: 27005527 [TBL] [Abstract][Full Text] [Related]
36. The impact of outpatient systemic anti-cancer treatment on patient costs and work practices. Collins DC; Coghlan M; Hennessy BT; Grogan L; Morris PG; Breathnach OS Ir J Med Sci; 2017 Feb; 186(1):81-87. PubMed ID: 27498210 [TBL] [Abstract][Full Text] [Related]
37. [The human and economic burden of cancer in France in 2014, based on the Sniiram national database]. Tuppin P; Pestel L; Samson S; Cuerq A; Rivière S; Tala S; Denis P; Drouin J; Gissot C; Gastaldi-Ménager C; Fagot-Campagna A Bull Cancer; 2017 Jun; 104(6):524-537. PubMed ID: 28285755 [TBL] [Abstract][Full Text] [Related]
38. Health Care Expenditure Burden of Cancer Care in the United States. Park J; Look KA Inquiry; 2019; 56():46958019880696. PubMed ID: 31583928 [TBL] [Abstract][Full Text] [Related]
39. The cost and burden of cancer in the European Union 1995-2014. Jönsson B; Hofmarcher T; Lindgren P; Wilking N Eur J Cancer; 2016 Oct; 66():162-70. PubMed ID: 27589247 [TBL] [Abstract][Full Text] [Related]
40. In-patient Expenditure Between 2012 and 2020 Concerning Patients With Liver Cirrhosis in Chongqing: A Hospital-Based Multicenter Retrospective Study. Tan J; Tang X; He Y; Xu X; Qiu D; Chen J; Zhang Q; Zhang L Front Public Health; 2022; 10():780704. PubMed ID: 35350474 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]